Novo Nordisk, Viatris settle patent dispute over Ozempic, Wegovy ...
WEB20 hours ago · Novo Nordisk (NVO) and Viatris (NASDAQ: VTRS) have reportedly reached an agreement in their dispute over U.S. patents protecting Novo’s popular weight-loss drugs Wegovy and Ozempic. The ...
Novo Nordisk settles US patent fight with Viatris over Ozempic, …
WEB22 hours ago · Oct 7 (Reuters) - Novo Nordisk (NOVOb.CO) and Viatris (VTRS.O) have agreed to resolve a patent dispute over Novo's blockbuster weight-loss drugs Ozempic and Wegovy, the companies told a U.S ...
Home | Viatris
WEBSep 18, 2024 · Press Releases. Viatris Announces the Pricing Terms of Maximum Tender Offer. Read More. Sep 18, 2024. Viatris Announces Early Tender Results and Increase of Pending Maximum Tender Offer. Read More. Sep 17, 2024. Viatris to Report Third Quarter 2024 Financial Results on November 7, 2024. Read More.
Viatris Inc. (VTRS) Latest Stock News & Headlines - Yahoo Finance
WEBGet the latest Viatris Inc. (VTRS) stock news and headlines to help you in your trading and investing decisions.
Viatris Announces Agreements on Remaining Planned …
WEBOct 1, 2023 · Viatris has executed an agreement to divest its API business in India to Iquest Enterprises, a privately held pharmaceutical company, also based in India. The transaction includes three manufacturing sites and a R&D lab in Hyderabad, three manufacturing sites in Vizag and third-party API sales. Viatris will …
Viatris Reports Fourth-Quarter and Full-Year 2023 Financial …
WEBFeb 28, 2024 · Viatris Inc. (NASDAQ: VTRS) today announced its financial results for the fourth quarter and full year 2023. Executive Commentary.
Viatris and Idorsia Enter Into Significant Global Research and ...
WEBFeb 28, 2024 · Combines Viatris' Financial Strength and Worldwide Operational Infrastructure With Idorsia's Proven, Highly Productive Drug Development Team and Innovation Engine. Deal Structure Reinforces Viatris' Disciplined Approach to Capital Allocation. Viatris Announces R&D Event to be Held March 27, 2024.
Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia ...
WEBPITTSBURGH, March 27, 2024 /PRNewswire/ -- At a meeting with the investment community today, Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will outline how it is continuing to evolve its R&D strategy to deliver on its goal of building a more durable, higher-margin portfolio of patented innovation on …
Viatris Announces Appointment of Scott A. Smith as CEO Effective …
WEBFeb 27, 2023 · Press Releases. Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023. Smith, a seasoned senior healthcare executive, will lead the company's previously announced Phase 2 strategy and execution. Board of Directors thanks Michael Goettler, who will support a smooth transition prior to his departure.
Viatris 2023 Sustainability Report: Expanding Contractor Training
WEB21 hours ago · I am thankful to my EHS team, contractors and the project team in supporting this safety goal." View the full 2023 Sustainability Report. Contact Info: Spokesperson: Viatris Website: https://www ...